Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program.
about
Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and preventionSelf-reported hepatitis C virus antibody status and risk behavior in young injectorsAre needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysisA review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users.Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugsSeroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review.Knowledge of Hepatitis B Virus Infection, Immunization with Hepatitis B Vaccine, Risk Perception, and Challenges to Control Hepatitis among Hospital Workers in a Nigerian Tertiary HospitalMolecular and contextual markers of hepatitis C virus and drug abuse.Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran.Prevention of viral hepatitis in the Nordic countries and Germany.Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug usersAcute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients.Bloodborne viral hepatitis infections among drug users: the role of vaccinationTransmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden.Historical epidemiology of hepatitis C virus (HCV) in selected countries.The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy.The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities.The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.The risk of cancer among persons with a history of injecting drug use in Sweden - a cohort study based on participants in a needle exchange program.Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program.Risk Factors and predictors of human immunodeficiency virus infection among injection drug users.Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country.
P2860
Q27014761-EDF67EBB-013D-4052-A866-0F3C9CE022D3Q27478003-A184E592-EC1D-4D8A-A500-A15DC56729E7Q28304793-5205580D-4474-4630-8BD4-A3C991B15B61Q33256564-29358B68-7210-41C9-B84C-91E3B3C21C36Q33618436-4C563FD6-D7BC-452F-8E00-4EFF3A30C771Q34637206-E8F34719-BE94-4DF7-92AD-50E857D207B6Q35061558-329241FD-770F-473C-94AD-FA301311514CQ35660841-444A9D53-7B49-4308-9CEB-13887D61D878Q35819898-8289F7DD-73DC-4E2A-AA8E-05312E85D190Q36229205-F3E3783D-14FA-42BA-91D3-A33057C31929Q36272770-86D4D92A-266E-49CC-A977-2FD2B6E5C53AQ36928238-226A4D09-4E5E-4D76-8181-71B6FBCD9816Q37167103-FB33FCF2-7796-43D7-8B18-DDA748FC4109Q37491694-7E88B49E-459A-484A-A14B-D0630C016435Q38203033-0071A65A-607F-466F-AECC-C131BD98D50AQ39075044-F9F3D961-9368-4214-83B7-25E6727D8E9CQ39860271-985D2E2E-545D-4393-BB47-AC9D2DD6628DQ40652912-C178B753-E199-4E4B-BC4E-3D33083274A6Q42632308-09397CBA-AEC5-45F3-8BB9-2D4FD473BFB9Q42720607-3F55B0B0-408B-4DEC-8F67-231C2C7081E5Q43988798-0CC2DCA1-42E6-4CA0-9341-CC36E7CAC773Q44163628-34ABEFBE-6435-4F7F-B111-084D0C75CF15Q44774582-F8CEB12E-4D8C-4FB0-9D25-9640A1F9103DQ45370954-0B0BA215-E39B-4074-8A8C-9B222A4B633DQ45440502-F7B65939-F3E6-43A8-9155-AD1025D9E545Q45509091-5E0FF421-F357-4387-8941-F71973DA6FF5Q51126531-5611DC23-3801-4E23-B3F8-1612570ACD5DQ51775017-D68656BE-0EA7-41D4-A9E7-045E85CE8339
P2860
Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Continued transmission of hepa ...... ringe/needle exchange program.
@en
Continued transmission of hepa ...... ringe/needle exchange program.
@nl
type
label
Continued transmission of hepa ...... ringe/needle exchange program.
@en
Continued transmission of hepa ...... ringe/needle exchange program.
@nl
prefLabel
Continued transmission of hepa ...... ringe/needle exchange program.
@en
Continued transmission of hepa ...... ringe/needle exchange program.
@nl
P2093
P2860
P1476
Continued transmission of hepa ...... ringe/needle exchange program.
@en
P2093
Moestrup T
Månsson AS
Nordenfelt E
P2860
P304
P356
10.1080/00365540050165875
P577
2000-01-01T00:00:00Z